{"title":"Epidemiology, characteristics, management, and survival of patients with malignant carotid body tumors: A systematic review and meta-analysis of current evidence.","authors":"Yong-Hong Wang, Ji-Hai Zhu, Wei Ma, Jia Yang, Hao Zhong, Jun-Jie Wu, Kai Wu, Anguo Hu, Jian-Ying Wu","doi":"10.1177/17085381251360125","DOIUrl":"https://doi.org/10.1177/17085381251360125","url":null,"abstract":"<p><p>Background and AimMalignant carotid body tumors (CBTs) represent a rare clinical entity, with existing studies limited by small sample sizes and fragmented data. This systematic review aims to: (1) Pool epidemiological estimates of malignant CBTs; (2) Characterize clinicopathological profiles; (3) Evaluate treatment modalities and survival outcomes; (4) Identify risk factors for malignant transformation.MethodsA comprehensive search of PubMed, Scopus, Cochrane Library, and Web of Science was conducted through January 1, 2024 for literatures with malignant CBTs. The incidence, clinicopathological features, management and survival of patients with malignant CBTs were pooled analyzed and described. Benign and malignant CBTs were compared to identify any relevant risk factors of malignant transformation for CBTs. Two independent reviewers performed study selection, data extraction, and quality assessment. All statistical analyses were performed using the standard statistical procedures provided in Review Manager 5.2 and Stata 12.0.ResultsA total of 99 reports and 447 patients with malignant CBTs were identified. The pooled results indicated that the incidence of malignant CBTs was 5% (4% ‒ 6%) with a mean age of 44.11 years. In addition, female patients with malignant CBTs accounted for 61% and 14.58% experienced bilateral lesions. 74.63% malignant CBTs were defined as Shamblin III with a mean maximal diameter of 5.19 cm. We found that compared to patients with benign CBTs, patients with malignant CBTs experienced significantly higher proportion of Shamblin III (OR 4.65; 95% CI 1.80-12.06) and preoperative symptoms (hoarseness/dysphonia) (OR 7.96; 95% CI 1.79-35.5) respectively. It was observed that patients with malignant CBTs experienced more vascular and neurologic complications including vascular reconstruction or repair (OR 19.22; 95% CI 6.23-59.3), overall neurological complication (OR 3.81; 95% CI 1.28-11.36) and permanent nerve deficits (OR 3.95; 95% CI 1.26-12.41) respectively.ConclusionsThis meta-analysis established that malignant CBTs were more likely to be Shamblin III with larger size and common in middle-aged female. The majority of patients with malignant CBTs experienced preoperative systems. Preoperative hoarseness/dysphonia was associated with malignancy. Malignant CBTs increased vascular and neurologic complications. Postoperative radiotherapy was mainly used for malignant CBTs. Cohort studies with enough sample size and long follow-up are required to clear the risk factors, treatment and survival of malignant CBTs.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251360125"},"PeriodicalIF":0.9,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-07-28DOI: 10.1177/17085381251360045
Benjamin Liu, Caroline Chung, Iman Mohammed, Chase Schlesselman, Todd R Vogel, Steven Cheung, Jonathan Bath
{"title":"Outcomes of unibody endoprosthesis for treatment of aortic aneurysmal pathology and aortoiliac occlusive disease.","authors":"Benjamin Liu, Caroline Chung, Iman Mohammed, Chase Schlesselman, Todd R Vogel, Steven Cheung, Jonathan Bath","doi":"10.1177/17085381251360045","DOIUrl":"https://doi.org/10.1177/17085381251360045","url":null,"abstract":"<p><p>ObjectiveUnibody Endoprosthesis (UBE) is a newer treatment modality for abdominal aortic pathology (AAP) and has increasingly been utilized for aortoiliac occlusive disease (AIOD). We report outcomes of patients undergoing UBE for AAP and AIOD.MethodsPatients (2016-2021) undergoing UBE were identified retrospectively at an academic institution. AAP included aneurysm/pseudoaneurysm/PAU. Chi-square and Kaplan-Meier analysis were used to evaluate outcomes by group.Results90 patients undergoing UBE were included with 39 patients undergoing AAP (43%) and AIOD treatment in 51 (57%). AAP patients were older (72.9 vs 62.5 years; <i>p</i> = .01), with a lower prevalence of female patients treated than AIOD (36% vs 57%; <i>p</i> = .04), diabetes (23% vs 45%; <i>p</i> = .03) and current smokers (46% vs 69%; <i>p</i> = .03). There were significant differences in arterial diameters with AAP patients exhibiting larger minimum aortic diameter (19 mm vs 15 mm; <i>p</i> < .0001), iliac (12.5 mm vs 9.8 mm; <i>p</i> < .0001), femoral (9 mm vs 6.9 mm; <i>p</i> < .0001), SFA (6.8 mm vs 5.2 mm; <i>p</i> < .0001) and profunda femoris (6 mm vs 4.9 mm; <i>p</i> = .002). Shorter surgery duration was seen with AAP than AIOD patients (135 min vs 194 min; <i>p</i> = .001). There were six major amputations in the overall cohort with two BKA and four AKA. There were no significant differences in unadjusted 30-day outcomes or mid-term outcomes between groups at a mean follow-up period of 20 months. Reinterventions over the follow-up period occurred in 9 limbs (5%) in the overall cohort with no significant associations between demographic or anatomic variables identified. Subgroup analysis of the whole cohort by sex revealed that female patients exhibited smaller minimum aortic diameter (14.9 mm vs 18.6 mm; <i>p</i> < .0001), common iliac (9.3 mm vs 12.5 mm; <i>p</i> < .0001), femoral (6.9 mm vs 8.7; <i>p</i> < .0001), SFA (5.2 mm vs 6.6 mm; <i>p</i> < .0001) and profunda femoris (4.9 mm vs 5.9 mm; <i>p</i> = .0006). Logistic regression analysis revealed an independent association between minimum aortic diameter (OR 1.61; 95% CI 1.0-2.4) and surgery length (OR 1.02; 95% CI 1-1.03) and overall mortality. Kaplan-Meier estimated survival at 36 months was 94% for AIOD and 84% for AAP (<i>p</i> = .23). At 36 months, primary patency was 78% for AIOD versus 100% for AAP (<i>p</i> = .002), primary-assisted patency was 94% for AIOD versus 100% for AAP (<i>p</i> = .12) and secondary patency for AIOD was 82% versus 100% for AAP (<i>p</i> = .008).ConclusionsUBE can be safely and effectively used for treating aortic aneurysmal pathology as well as aortoiliac occlusive disease in selected patients. Despite the differing pathologies, outcomes are similar with a low reintervention rate and excellent mid-term patency of the intervention. Interestingly, an independent association between mortality and small minimum aortic diameter was seen, further reinforcing AIOD as a marker for overall m","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251360045"},"PeriodicalIF":0.9,"publicationDate":"2025-07-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144733533","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-07-18DOI: 10.1177/17085381251360121
Teresa Machado, Fábio Sousa-Nunes, João Rocha-Neves, Inês Machado, José Fernando Teixeira, Pedro Videira-Reis, Marina Dias-Neto
{"title":"ABO-blood groups and outcomes after abdominal aortic aneurysm repair.","authors":"Teresa Machado, Fábio Sousa-Nunes, João Rocha-Neves, Inês Machado, José Fernando Teixeira, Pedro Videira-Reis, Marina Dias-Neto","doi":"10.1177/17085381251360121","DOIUrl":"https://doi.org/10.1177/17085381251360121","url":null,"abstract":"<p><p>ObjectivesTo analyze the association between blood groups (ABO and Rh) and long-term outcomes following abdominal aortic aneurysm (AAA) repair.MethodsRetrospective cohort study including all patients submitted to elective AAA surgery between 2009 and 2019. Outcomes were mortality and major adverse cardiac events (MACE).ResultsOf the 333 patients included in this study, 49.5% had blood type A, followed by 39.3% with type O, 8.1% with type B and 3.1% with type AB. Regarding Rh factor, 82.4% were Rh<sup>+</sup> and 17.6% were Rh<sup>-</sup>. The distribution of the blood phenotypes was similar between AAA patients and the Portuguese population. The median follow-up time was 75.4 months (interquartile range 65.8-81.6). Patient survival rates at 1 and 5 years were 89.3% (95% Confidence Interval 86.0-92.7) and 61.9% (56.2-68.2), respectively. MACE-free survival at 1 and 5 years was 85.7% (81.9-89.5) and 57.6% (51.9-64.0), respectively. Survival and MACE-free survival rates were similar across blood group types. Age, maximum aortic diameter, peripheral arterial disease and chronic obstructive pulmonary disease were independent predictors of mortality. Maximum aortic diameter, estimated glomerular filtration rate, cerebrovascular disease and type of surgery were independent predictors of MACE.ConclusionWe found no association between the blood types and the prevalence of AAA or adverse outcomes following AAA repair.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251360121"},"PeriodicalIF":1.0,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144660329","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-07-14DOI: 10.1177/17085381251361573
Wildor Samir Cubas, David Bellido-Yarleque, Fernando Bautista-Sánchez, Ludwig Cáceres-Farfán, Josias Ríos-Ortega
{"title":"Latin America's role in the aortic endovascular revolution: Are we truly in the game?","authors":"Wildor Samir Cubas, David Bellido-Yarleque, Fernando Bautista-Sánchez, Ludwig Cáceres-Farfán, Josias Ríos-Ortega","doi":"10.1177/17085381251361573","DOIUrl":"https://doi.org/10.1177/17085381251361573","url":null,"abstract":"<p><p>BackgroundThe global adoption of endovascular aortic techniques has progressed rapidly, yet the extent of Latin America's participation in this revolution requires comprehensive evaluation. This review examines the region's current capabilities, innovations, and barriers in aortic endovascular therapy.MethodsWe conducted a systematic analysis of published experiences and institutional reports from across Latin America, focusing on three key areas: ascending/arch aortic interventions, thoracoabdominal repairs, and endoleak management strategies.ResultsThe region has demonstrated significant progress in adopting complex endovascular therapies despite resource limitations. Several centers have successfully implemented advanced techniques, including total percutaneous arch repairs, hybrid debranching procedures, and customized endograft solutions. Experience with thoracoabdominal pathologies shows promising outcomes with fenestrated and branched endografts, while innovative approaches to endoleak management have been developed, particularly for challenging type II and III cases. However, variability in outcomes persists due to disparities in technology access, training opportunities, and follow-up protocols. The available evidence, while growing, remains largely limited to single-center experiences with modest sample sizes.ConclusionLatin America has made measurable strides in aortic endovascular therapy, demonstrating both technical capability and innovative adaptations to local challenges. The establishment of a Latin American Aortic Registry (LATAR) would address critical gaps in data standardization, facilitate outcome benchmarking, and promote equitable technology dissemination. Such structured collaboration is essential for the region to fully participate in the global advancement of aortic care.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251361573"},"PeriodicalIF":1.0,"publicationDate":"2025-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144627140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-07-10DOI: 10.1177/17085381251360068
Meng-Jie Shi, Xi Yuan, Yan Yan, Rui-Peng Zhang, Fei Liu, Shi-Cai He, Hui Wang
{"title":"Prioritizing relieving iliac venous compression contributes to treating varicose veins of lower extremities patients with May-Thurner syndrome.","authors":"Meng-Jie Shi, Xi Yuan, Yan Yan, Rui-Peng Zhang, Fei Liu, Shi-Cai He, Hui Wang","doi":"10.1177/17085381251360068","DOIUrl":"https://doi.org/10.1177/17085381251360068","url":null,"abstract":"<p><p>ObjectiveWe suspect that the May-Thurner syndrome (MTS) is the main etiology of secondary varicose veins of the lower extremities (VVLE). However, there is no definitive agreement on the priority and necessity of relieving iliac vein compression when treating patients with VVLE and MTS.MethodIn this study, according to the results of anterograde venography of lower extremity, 99 patients were divided into two groups, namely, simple VVLE (<i>n</i> = 66) and VVLE-MTS groups (<i>n</i> = 33). The patients in the former group only received sclerotherapy, while the patients in later group received the combination treatments of intravascular balloon dilatation, stent placement of iliac vein, and sclerotherapy. After surgery, we applied VVCS score, postoperative recanalization rate, and improvement in clinical symptom to assess therapeutic effects.ResultsVCSS score: At 1 week, 1 month, 3 months, and 6 months after operation, there were significant differences between group A and group B (<i>p</i> < 0.01), the difference of VCSS: compared with preoperation, there was statistical difference between group A and group B at 1 week after operation (<i>p</i> < 0.01), there was no statistical difference 6 months after operation (<i>p</i> = 0.052); Postoperative recanalization: cumulative trunk recanalization events 6 months after surgery There was no statistical difference between (<i>p</i> = 0.192) and branch recanalization events (<i>p</i> = 0.207). When the two events were combined to increase the positive rate, no statistical difference was found. However, after stratifying patients, mild (CEAP2-3) and moderate (CEAP4) patients were obtained. There was no statistical difference in the incidence of recanalization events between the two groups, but there was a statistical difference between severe (CEAP5-6) groups (<i>p</i> = 0.025).ConclusionIt was great of importance and necessity of solving iliac vein compression prior to treating VVLE when handling patients with VVLE and MTS, especially for the cases with high CEAP score.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251360068"},"PeriodicalIF":1.0,"publicationDate":"2025-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144601719","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-07-09DOI: 10.1177/17085381251360087
Renxi Li, Anton Sidawy, Bao-Ngoc Nguyen
{"title":"Endovascular aneurysm repair for patients with disseminated cancer: A propensity-score matched study from ACS-NSQIP database from 2012-2022.","authors":"Renxi Li, Anton Sidawy, Bao-Ngoc Nguyen","doi":"10.1177/17085381251360087","DOIUrl":"https://doi.org/10.1177/17085381251360087","url":null,"abstract":"<p><p>BackgroundDisseminated cancer may complicate decision-making processes for major surgical interventions, including endovascular aneurysm repair (EVAR) for abdominal aortic aneurysm (AAA). However, the postoperative outcomes of EVAR in patients with disseminated cancer have not been well-established. This study aimed to explore the impact of preoperative disseminated cancer on 30-day outcomes of non-ruptured EVAR.MethodsPatients who underwent infrarenal EVAR were identified in ACS-NSQIP targeted database from 2012 to 2022. Exclusion criteria included age <18 years, ruptured aneurysm, acute intraoperative conversion to open repair, and emergency cases. A 1:3 propensity-score matching was used to match demographics, baseline characteristics, aneurysm diameter, distant aneurysm extent, anesthesia, and concomitant procedures between patients with and without preoperative disseminated cancer. Thirty-day postoperative EVAR outcomes were examined.ResultsThere were 154 (0.80%) patients with disseminated cancer who underwent non-ruptured EVAR. Meanwhile, 19,109 patients without disseminated cancer went under EVAR, where 462 of them were matched to all patients with disseminated cancer. After propensity-score matching, patients with and without disseminated cancer had comparable mortality rates (5.19% vs 4.76%, <i>p</i> = 0.83). However, patients with disseminated cancer had higher lower extremity ischemia (2.60% vs 0.43%, <i>p</i> = 0.04), unplanned reoperation (9.74% vs 3.90%, <i>p</i> = 0.01), and 30-day readmission (19.48% vs 10.61%, <i>p</i> = 0.01).ConclusionDisseminated cancer is significantly more prevalent among patients undergoing EVAR than the general population (0.05%), likely due to shared pathophysiology between AAA development and the incidence and progression of cancer. While EVAR is relatively safe in terms of short-term outcomes in patients with disseminated cancer, the long-term prognosis for these patients needs further investigation.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251360087"},"PeriodicalIF":1.0,"publicationDate":"2025-07-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144592455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-07-08DOI: 10.1177/17085381251360074
Vy Thuy Ho, Shernaz Sophia Dossabhoy, Lakshika Tennakoon, Jason Tin Aye Lee, Lisa Marie Knowlton
{"title":"Factors associated with in-hospital amputation after revascularization for lower extremity trauma.","authors":"Vy Thuy Ho, Shernaz Sophia Dossabhoy, Lakshika Tennakoon, Jason Tin Aye Lee, Lisa Marie Knowlton","doi":"10.1177/17085381251360074","DOIUrl":"https://doi.org/10.1177/17085381251360074","url":null,"abstract":"<p><p>ObjectivesWhile concomitant vascular injury is associated with an increased risk of amputation following lower extremity trauma, risk factors for amputation after attempted revascularization are lesser known. In centers where dedicated vascular traumatic expertise is not available, a lack of guidance regarding high-risk vascular trauma may limit efforts to appropriately triage and transfer patients to a higher level of care. We identified factors associated with in-hospital amputation after revascularization for isolated lower extremity trauma.MethodsThe American College of Surgeons Trauma Quality Improvement Program (ACS TQIP) is a multicenter, prospectively maintained database containing deidentified traumatic admissions data for over 900 trauma centers in the United States. From 2017 to 2021, ACS TQIP was queried for adult patients undergoing arterial revascularization following isolated lower extremity trauma. Injury-related variables were derived from structured data fields, Injury Severity Scores, and Abbreviated Injury Scores. The primary endpoint was post-revascularization in-hospital lower extremity amputation. Univariate and multivariate logistic regression of demographic data, medical history, and injury-related variables were performed to identify factors associated with post-revascularization amputation.ResultsOf 5669 patients undergoing revascularization, 10.2% underwent amputation a median 8.31 days after their surgical procedure. Most revascularizations were done via open surgical approach (81.9%), followed by endovascular (13.8%) and hybrid (4.3%) methods. Amputated patients were older (39.5 vs 35.6 years, <i>p</i> < 0.001, Table 1) and more likely to have a preoperative history of peripheral arterial disease (1.4% vs 0.6%, <i>p</i> = 0.017). On multivariate logistic regression, blunt mechanism (OR 4.80, <i>p</i> < 0.001, Table 2), popliteal arterial injury (OR 2.11, <i>p</i> < 0.001), and concurrent bony injury (OR 2.03, <i>p</i> < 0.001) were independently associated with amputation.ConclusionsIn the multicenter American College of Surgeons Trauma Quality Improvement Program, the overall rate of post-revascularization amputation in patients with isolated lower extremity trauma was 10.20%. Amputation risk was higher in patients with advanced age and comorbidity, suggesting that triage for revascularization already incorporates an evaluation of patient frailty. In multivariate analysis, blunt mechanism of injury, popliteal artery injury, and bony injury were independently associated with amputation. Each additional hour between admission and revascularization was associated with greater amputation risk, highlighting the importance of efforts to expediently and appropriately triage patients at with high-risk injuries to optimize limb salvage outcomes.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251360074"},"PeriodicalIF":1.0,"publicationDate":"2025-07-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144585003","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-07-07DOI: 10.1177/17085381251360066
Renxi Li, Anton Sidawy, Bao-Ngoc Nguyen
{"title":"Higher risks of thirty-day mortality and thromboembolism in disseminated cancer patients undergoing carotid endarterectomy: A perspective from the ACS-NSQIP database from 2011 to 2022.","authors":"Renxi Li, Anton Sidawy, Bao-Ngoc Nguyen","doi":"10.1177/17085381251360066","DOIUrl":"https://doi.org/10.1177/17085381251360066","url":null,"abstract":"<p><p>BackgroundAtherosclerosis in carotid arteries can lead to carotid stenosis, where carotid endarterectomy (CEA) is the first-line intervention. Malignancy has a two-way relationship with atherosclerosis, where they share common molecular pathways in their pathophysiology. However, the postoperative outcomes of CEA in patients with disseminated cancer remain unclear. This study aimed to examine the 30-day outcomes of CEA in patients with disseminated cancer.MethodsPatients with and without disseminated cancer who underwent CEA were identified in the ACS-NSQIP targeted database from 2011 to 2022. Patients with age <18 years were excluded. A 1:5 propensity-score matching was used to address preoperative differences between the cohorts. Thirty postoperative outcomes were examined.ResultsThere were 148 (0.37%) patients with disseminated cancer who went under CEA. Meanwhile, 40,028 patients without disseminated cancer underwent CEA, where 740 of them were matched to those with disseminated cancer. After 1:5 propensity-score matching, disseminated cancer patients had higher risks of 30-day mortality (4.73% vs 1.62%, <i>p</i> = .03), and deep vein thrombosis (3.38% vs 0.68%, <i>p</i> = .01), while stroke, transient ischemic attacks, and other 30-day outcomes were comparable between the groups.ConclusionPatients with disseminated cancer had higher thromboembolism and mortality after CEA. Given the prevalence of cancer-related thrombosis and its associated increased mortality risk, effective prophylaxis and treatment for venous thromboembolism, such as low molecular weight heparin administration, should be essential in patients with disseminated cancer. These findings can also be valuable for preoperative risk stratification and in determining the surgical candidacy of patients with disseminated cancer in CEA. CEA for asymptomatic patients with disseminated cancer may require further justification given their elevated perioperative risk.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251360066"},"PeriodicalIF":1.0,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144576370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An investigation of the relationship between pain, quality of life, and venous refill time in chronic venous insufficiency.","authors":"Selda Karaveli Cakir, Gökçe Şirin, Sinem Eryiğit, İlknur Çalışkan, Hasan Toz","doi":"10.1177/17085381251359318","DOIUrl":"https://doi.org/10.1177/17085381251359318","url":null,"abstract":"<p><p>ObjectivePhotoplethysmography provides information about global venous function and is also used to assess the time required to refill the veins within the dermis or the venous refill time. This descriptive cross-sectional study aims to investigate the relationship between pain, quality of life, and venous refill time in patients with chronic venous insufficiency.MethodsThe study was conducted on a sample of 72 patients diagnosed with chronic venous insufficiency. Data were collected using the Descriptive Characteristics Form, the Short-Form McGill Pain Questionnaire, and the Venous Insufficiency Epidemiological and Economic Study: The Quality of Life/Symptoms Scale (VEINES-QOL/Sym), and venous refill time was obtained by using photoplethysmography.ResultsThe mean age of the patients included in the study was 41.24 ± 13.58 years, and 54.2% were female. A positive correlation was found between photoplethysmography and VEINES-QOL/Sym, whereas a negative correlation was found with the McGill Pain Questionnaire (<i>p</i> < .001). The results showed that photoplethysmography significantly predicted VEINES-QOL/Sym and McGill Pain Questionnaire with a statistically significant correlation (<i>p</i> < .001).ConclusionsThe results of this study indicate that venous refill time has a significant impact on both pain and quality of life. The findings underscore the need to mitigate the negative impact of CVI on quality of life in patients diagnosed with CVI. In this regard, it is of great importance to identify the factors that negatively affect the quality of life of patients with CVI and to provide counseling services for these factors.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"17085381251359318"},"PeriodicalIF":1.0,"publicationDate":"2025-07-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144561313","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
VascularPub Date : 2025-06-01Epub Date: 2024-05-10DOI: 10.1177/17085381241254429
W Samir Cubas, Franco Albán-Sánchez, Cesar Calle-Blácido, Milagros Salazar-Cuizano, Johnny Mayta-Rodríguez, Carlos Pachas-Canales, Mariano Cuentas-Jara, Alexis Sánchez-Huamán, Jessica Pedroza-Silvera
{"title":"3D impression to facilitate in situ surgical renal segmental artery aneurysm repair: A novel open approach option for an unusual vascular condition.","authors":"W Samir Cubas, Franco Albán-Sánchez, Cesar Calle-Blácido, Milagros Salazar-Cuizano, Johnny Mayta-Rodríguez, Carlos Pachas-Canales, Mariano Cuentas-Jara, Alexis Sánchez-Huamán, Jessica Pedroza-Silvera","doi":"10.1177/17085381241254429","DOIUrl":"10.1177/17085381241254429","url":null,"abstract":"<p><p>ObjectivesRenal Artery Aneurysms (RAA) affect approximately 0.01%-0.97% of the population. Early diagnosis, thorough 3D-preoperative planning, and timely surgical treatment may offer effective and safe management.MethodsWe report the open reparation of a segmental renal artery saccular aneurysm close to the bifurcation with detailed preoperative planning based on 3D printing, and with successful postoperative results.ResultsWe report the case of a 36-year-old man with a 3.5 × 5 cm segmental renal artery saccular aneurysm close to the bifurcation, for which endovascular management was ruled out and open management was chosen with detailed preoperative planning based on 3D printing and with successful postoperative results.ConclusionsWhen an open approach is chosen in the RAA treatment, a detailed study of the anatomical configuration of the RAAs is mandatory, and life-size 3D printing is a valuable tool that could contribute to the operative technique, reduce surgical times associated with renal ischemia and provide minute details that would make a clear anatomical difference during in situ repair.</p>","PeriodicalId":23549,"journal":{"name":"Vascular","volume":" ","pages":"609-612"},"PeriodicalIF":1.0,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140904638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}